eCM Journal Scope

eCM Journal (European Cells & Materials) provides a multidisciplinary high-level forum for biomedical research (Orthopaedics, Cell & tissue engineering, Biomaterials science, and Biomedical engineering). Research fields include, but are not limited to Musculoskeletal (Infection, Trauma, Maxillofacial and Spine), Stem cells, Drug/gene carrier design, Bionanomedicine, and Application of biomaterials.

eCM Journal is published by Forum Multimedia Publishing LLC., Part of IMR Press.

• Biomedical materials

Manuscripts must have an important biological dimension, focusing on the various effects of biological materials at the cell, tissue or organism level. In vitro cytocompatibility studies should use primary cells or more than one cell line and provide more than just simple descriptions of cell viability, spreading, proliferation, mineralisation etc. Major improvements with in vitro, ex vivo or in vivo models and relevant opinion papers may be considered.

Note: Papers that focus only on material properties or biomechanical properties (alone or in combination, without a strong biological dimension) will not be entertained. Manuscripts on effects of surfaces, coatings, additives etc. in preventing bacterial adhesion must also consider the effect on eukaryotic cells (to be mentioned within the abstract) or refer to previously published data using the exact same surfaces. Surgical studies that are unrelated to the cellular and tissue mechanisms or materials within the body will not be considered.

• Tissue Engineering and Regenerative Medicine (TERM)

Manuscripts concerning the repair or regeneration of connective and mineralized tissues within the body will be considered. Manuscripts also concern the growth and directed differentiation of stem cells (including but not limited to adult stem cells, tumor stem cells, embryonic stem cells, mesenchymal stem cells, induced pluripotent stem cells), cell therapy and transplantation, the biological mechanisms of stem cell differentiation, and their research in tissue engineering and medical engineering.

Note: TERM papers where only biomechanical testing is utilized without in-depth biological research will not be considered. Basic physiological and pathological research related to the spinal cord, neural tissue, smooth muscle, and myocardium that are not related to biomedical engineering will not be considered. The paper must mention the effects at the cellular, tissue, or organic level. The use of mixed donor cells (from multiple sources) should be avoided, and if unavoidable, the reasons for their use should be convincingly explained in the manuscript (as well as in the cover letter). Orthopedic or biomedical engineering content without cellular level research or unrelated to materials will not be considered. Technical specifications and papers that only focus on calculations, materials, or biomechanical models are not accepted.

• Orthopedics

Manuscripts concerning the prevention, diagnosis and treatment of infection related to body tissue and musculoskeletal, and major improvements with in vitro or ex vivo models. This includes, but is not limited to fracture-related infection, peri-prosthetic joint infection, osteomyelitis, septic arthritis, osteosarcoma-related research, etc. Bacteria-host interaction studies and basic pathophysiology of infection will be considered once the content is related to musculoskeletal and other infection.

Note: The clinical relevance of the work must be briefly mentioned within the abstract and in more detail in the paper. Poor abstracts, which do not concisely cover the papers contents will not be sent for review.

• Others
Manuscripts developing new biomaterials, drug carriers and bioengineering methods, etc. are required to provide sufficient research with in vitro, ex vivo, or biological mechanism. Incremental steps in research will not be entertained by eCM journal.